XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (6837)	7/29/1998 12:05:00 PM
From: Bluegreen	Read Replies (1) of 17367

Bob, looks like you did all that road work for nothing. Richard Harmon must have been wearing his Sunday pants and didn't want to get them dirty. Have to admit though Little Richard is good in the idle gossip category. To: Robert K. (5388 ) From: Richard Harmon Wednesday, Jul 29 1998 11:36AM ET Reply # of 5390 Bob: I answered your question. I said "To answer your question directly...... I don't know". Prophylaxis of sepsis is a more promising ballpark than the venue for previous XOMA efforts, and, as I've said many times and IMO, the trials are well designed and conceived. Let's hope that the results of the trauma trial are positive. You want an answer outside of the context of the company/management, XOMA's current market cap, risk:reward ratio relative to other biotechs, etc. You now have such. I have long traded the issue with marked success, and I hope to continue to do such. Good luck. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next